Correlation of in Vivo Neuroimaging Abnormalities with Postmortem Human Immunodeficiency Virus Encephalitis and Dendritic Loss

Archives of Neurology

Volumn 61, Issue 3, 2004, Pages 369-376

  Archibald, Sarah L ^a,e,f   Masliah, Eliezer ^b,d   Fennema Notestine, Christine ^a,e   Marcotte, Thomas D ^a   Ellis, Ronald J ^b   McCutchan, J Allen ^c   Heaton, Robert K ^a   Grant, Igor ^a   Mallory, Margaret ^b   Miller, Aida ^b   Jernigan, Terry L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Vet Aff S Diego Healthcare System   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUTOPSY; BRAIN CORTEX; CAUDATE NUCLEUS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DENDRITE; FEMALE; HIPPOCAMPUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; IN VIVO STUDY; MALE; MORPHOMETRICS; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PRIORITY JOURNAL; RISK; SEROLOGY; UNITED STATES; UNIVERSITY; VIRUS ENCEPHALITIS; WHITE MATTER;

ADULT; ANTIGENS, CD45; AXONS; BRAIN; CASE-CONTROL STUDIES; DENDRITES; ECHO-PLANAR IMAGING; ENCEPHALITIS; FEMALE; HIV; HIV ENVELOPE PROTEIN GP41; HIV SEROPOSITIVITY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; MALE; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; NEURODEGENERATIVE DISEASES; PARVALBUMINS;

EID: 12144289452     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.3.369     Document Type: Article

References (41)

1. Jellinger KA, Setinek U, Drlicek M, Bohm G, Steurer A, Lintner F. Neuropathology and general autopsy findings in AIDS during the last 15 years. Acta Neuropathol (Berl). 2000;100:213-220.
2. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS. 2000;14:69-74.
3. Wu DT, Woodman SE, Weiss JM, et al. Mechanisms of leukocyte trafficking into the CNS. J Neurovirol. 2000;6(suppl 1):S82-S85.
4. Budka H, Wiley CA, Kleihues P, et al. HIV-associated disease of the nervous system: review of nomenclature and proposal for neuropathology-based terminology. Brain Pathol. 1991;1:143-152.
5. Masliah E, Ge N, Morey M, DeTeresa R, Terry R, Wiley CA. Cortical dendritic pathology in human immunodeficiency virus encephalitis. Lab Invest. 1992;66:285-291.
6. Langford D, Masliah E. Crosstalk between components of the blood brain barrier and cells of the CNS in microglial activation in AIDS. Brain Pathol. 2001;11:306-312.
7. Bell JE, Brettle RP, Chiswick A, Simmonds P. HIV encephalitis, proviral load and dementia in drug users and homosexuals with AIDS: effect of neocortical involvement. Brain. 1998;121:2043-2052.
8. Adle-Biassette H, Chrėtien F, Wingertsmann L, et al. Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol. 1999;25:123-133.
9. Wiley CA, Achim C. Human immunodeficiency virus encephalitis is the pathological correlate of dementia in acquired immunodeficiency syndrome. Ann Neurol. 1994;36:673-676.
10. Heaton RK, Velin RA, McCutchan JA, et al. Neuropsychological impairment in human immunodeficiency virus infection: implications for employment. Psychosom Med. 1994;56:8-17.
11. Marcotte TD, Heaton RK, Wolfson T, et al, the HNRC Group. The impact of HIV-related neuropsychological dysfunction on driving behavior. J Int Neuropsychol Soc. 1999;5:579-592.
12. Ellis RJ, Deutsch R, Heaton RK, et al, San Diego HIV Neurobehavioral Research Center Group. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol. 1997;54:416-424.
13. Jarvik JG. Acquired immunodeficiency syndrome: magnetic resonance patterns of brain involvement with pathological correlation. Arch Neurol. 1988;45:731-736.
14. Levy RM, Rosenbloom S, Perrett LV. Neuroradiologic findings in AIDS: a review of 200 cases. AJR Am J Roentgenol. 1986;147:977-983.
15. Olsen WL, Longo FM, Mills CM, Norman D. White matter disease in AIDS: findings at MR imaging. Radiology. 1988;169:445-448.
16. Flowers CH, Mafee MF, Crowell R, et al. Encephalopathy in AIDS patients: evaluation with MR imaging. AJNR Am J Neuroradiol. 1990;11:1235-1245.
17. Post MJ, Berger JR, Quencer RM. Asymptomatic and neurologically symptomatic HIV-seropositive individuals: prospective evaluation with cranial MR imaging. Radiology. 1991;178:131-139.
18. Jernigan TL, Archibald S, Hesselink JR, et al, the HNRC Group. Magnetic resonance imaging morphometric analysis of cerebral volume loss in human immunodeficiency virus infection. Arch Neurol. 1993;50:250-255.
19. Stout JC, Archibald SL, Jernigan TL, et al, HIV Neurobehavioral Research Center Group. Progressive cerebral volume loss in human immunodeficiency virus infection: a longitudinal volumetric magnetic resonance imaging study. Arch Neurol. 1998;55:161-168.
20. Dal Pan GJ, McArthur JH, Aylward E, et al. Patterns of cerebral atrophy in HIV-1-infected individuals: results of a quantitative MRI analysis. Neurology. 1992;42:2125-2130.
21. Aylward EH, Henderer JD, McArthur JC, et al. Reduced basal ganglia volume in HIV-1-associated dementia: results from quantitative neuroimaging. Neurology. 1993;43:2099-2104.
22. Aylward EH, Brettschneider PD, McArthur JC, et al. Magnetic resonance imaging measurement of gray matter volume reductions in HIV dementia. Am J Psychiatry. 1995;152:987-994.
23. Miller RF, Lucas SB, Hall-Craggs MA, et al. Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS. J Neurol Neurosurg Psychiatry. 1997;62:346-351.
24. Heindel WC, Jernigan TL, Archibald SL, Achim CL, Masliah E, Wiley CA. The relationship of quantitative brain magnetic resonance imaging measures to neuropathologic indexes of human immunodeficiency virus infection. Arch Neurol. 1994;51:1129-1135.
25. Filippi CG, Sze G, Farber SJ, Shahmanesh M, Selwyn PA. Regression of HIV encephalopathy and basal ganglia signal intensity abnormality at MR imaging in patients with AIDS after the initiation of protease inhibitor therapy. Radiology. 1998;206:491-498.
26. Masliah E, Heaton RK, Marcotte TD, et al, the HNRC Group. Dendritic injury is a pathological substrate for human immunodeficiency virus-related cognitive disorders: the HIV Neurobehavioral Research Center. Ann Neurol. 1997;42:963-972.
27. Jernigan TL, Ostergaard AL, Fennema-Notestine C. Mesial temporal, diencephalic, and striatal contributions to deficits in single word reading, word priming, and recognition. J Int Neuropsychol Soc. 2001;7:63-78.
28. Masliah E, Achim CL, Ge N, DeTeresa R, Terry RD, Wiley CA. Spectrum of human immunodeficiency virus-associated neocortical damage. Ann Neurol. 1992;32:321-329.
29. Wiley CA, Schrier RD, Morey M, Achim C, Venable JC, Nelson JA. Pathogenesis of HIV encephalitis. Acta Pathol Jpn. 1991;41:192-196.
30. Achim CL, Heyes MP, Wiley CA, Quantitation of human immunodeficiency virus, immune activation factors, and quinolinic acid in AIDS brains. J Clin Invest. 1993;91:2769-2775.
31. Wiley CA, Soontornniyomkij V, Radhakrishnan L, et al. Distribution of brain HIV load in AIDS. Brain Pathol. 1998;8:277-284.
32. Glass JD, Wesselingh SL, Seines OA, McArthur JC. Clinical neuropathologic correlation in HIV-associated dementia. Neurology. 1993;43:2230-2237.
33. Liu Y, Tang XP, McArthur JC, Scott J, Gartner S. Analysis of human immunodeficiency virus type 1 gp160 sequences from a patient with HIV dementia: evidence for monocyte trafficking into brain. J Neurovirol. 2000;6(suppl 1):S70-S81.
34. Persidsky Y, Zheng J, Miller D, Gendelman HE. Mononuclear phagocytes mediate blood-brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol. 2000;68:413-422.
35. Raja F, Sherriff FE, Morris CS, Bridges LR, Esiri MM. Cerebral white matter damage in HIV infection demonstrated using beta-amyloid precursor protein immunoreactivity. Acta Neuropathol (Berl). 1997;93:184-189.
36. McClernon DR, Lanier R, Gartner S, et al. HIV in the brain: RNA levels and patterns of zidovudine resistance. Neurology. 2001;57:1396-1401.
37. Liuzzi GM, Mastroianni CM, Fanelli M, et al. Myelin degrading activity in the CSF of HIV-1-infected patients with neurological diseases. Neuroreport. 1994;6:157-160.
38. Smith TW, DeGirolami U, Henin D, Bolgert F, Hauw JJ. Human immunodeficiency virus (HIV) leukoencephalopathy and the microcirculation. J Neuropathol Exp Neurol. 1990;49:357-370.
39. Power C, Kong PA, Crawford TO, et al. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol. 1993;34:339-350.
40. Hall M, Whaley R, Robertson K, Hamby S, Wilkins J, Hall C. The correlation between neuropsychological and neuroanatomic changes over time in asymptomatic and symptomatic HIV-1-infected individuals. Neurology. 1996;46:1697-1702.
41. Raghavan R, Stephens EB, Joag SV, et al. Neuropathogenesis of chimeric simian/human immunodeficiency virus infection in pig-tailed and rhesus macaques. Brain Pathol. 1997;7:851-861.